Global Smart Insulin Pens Market Report 2024, Featuring Profiles of Companion Medical, Emperra, Eli Lilly, Bigfoot Biomedical, Diamesco, Pendiq, Medtronic, Diabnext, Diabecare and Capillary Biomedical
25 mars 2024 12h13 HE
|
Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Global Smart Insulin Pens Market" report has been added to ResearchAndMarkets.com's offering.The global smart insulin pens market accounted for USD...
CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
11 mars 2024 09h57 HE
|
Dyadic International, Inc.
In a release issued under the same headline on Monday, March 11th by Dyadic International, Inc. (NASDAQ: DYAI), please note that the city in the dateline should be JUPITER, Fla. not JUNIPER, Fla. The...
Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
11 mars 2024 08h30 HE
|
Dyadic International, Inc.
JUNIPER, Fla., March 11, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Global Emerging Insulin Drug and Delivery Technologies Market Analysis: Smart Pens Unveiled as Fastest-Growing Segment, Predicted to Register CAGR of 12.6% During 2023-2028
08 mars 2024 04h15 HE
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials" report has been added to ResearchAndMarkets.com's...
Global Insulin Pen Market Report 2024: Data from 2020-2022, Estimates for 2023 and Compound Annual Growth Rates Projections through 2028
22 févr. 2024 11h17 HE
|
Research and Markets
Dublin, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Insulin Pen Market" report has been added to ResearchAndMarkets.com's offering. The global insulin pen market was valued at $9.9 billion in...
Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033, Featuring Novo Nordisk, Eli Lilly and Sanofi
14 févr. 2024 11h59 HE
|
Research and Markets
Dublin, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The "Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033" report has been added to ResearchAndMarkets.com's...
North America Sulfonylureas Market Projected to Grow, Hitting USD 3.35 Billion Valuation by 2028 with Notable CAGR of 1.90%
30 janv. 2024 20h00 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "North America Sulfonylureas Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ...
Europe Insulin Pens Market Projected to Reach USD 2.29 Billion by 2028 - Technological Innovations and Rising Diabetes Prevalence Fueling Growth
30 janv. 2024 19h58 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Insulin Pens Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ResearchAndMarkets.com's...
RYZODEG Drug & Market Forecast Report 2023-2032: Reveals Comprehensive Insights for Type 1 Diabetes Mellitus Treatment - Mechanism of Action, Clinical Assessments, Market Dynamics, Emerging Competitors
30 janv. 2024 06h58 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "RYZODEG Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Offering an in-depth analysis of the...
Cell Therapies for Type 1 Diabetes: 2023-2030 Industry Outlook Featuring Analysis of Leading Players Novo Nordisk, Sanofi, Vertex Pharmaceuticals, Sernova, and Throne Biotechnologies
30 janv. 2024 04h49 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapies for Type 1 Diabetes (2023 Edition): Global and Country Analysis By Epidemiology, Pipeline and Target Market Assessment" report has been...